A REVIEW OF NEMBUTAL ORAL LIQUID

pentobarbital will reduce the extent or impact of linagliptin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Use of different treatments is strongly advised when linagliptin will be to be administered which has a CYP3A4 inducerContraindicated (one)pentobarbital will minimize the level or effect of lumacaftor/ivacaftor